| Pharmaceutical active ingredients: |
| Betamethasone AcetateBetamethasone Sodium Phosphate |
| Available forms, composition and doses of Celeston Chronodose: |
| Injectable; Injection; Betamethasone Acetate 3 mg; Betamethasone Sodium Phosphate 3.945 mg / ml |
| Celeston Chronodose medical category: |
| Human:AdrenalsAnti-inflammatory agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AC01 - BetamethasoneH02AB01 - Betamethasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Butasona RL | Betamethasone Acetate; Betamethasone Sodium Phosphate | Fabra Laboratorios |
| Celesdepot | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough |
| Celestan Depot | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough; Essex |
| Celestene Chronodose | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough |
| Celeston Bifas | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough |
| Celestone Chronodose | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough; Essex |
| Celestone Soluspan | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough; Bayer Schering Pharma; Merck |
| Cidoten Rapilento | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough |
| Cidoten Rapilento con Lidocaina | Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough |
| Corteroid Retard | Betamethasone Acetate; Betamethasone Sodium Phosphate | Disprofarma |